Administration of a DNA-based FAP vaccine enabled killing of CAF by tumor-infiltrating CD8, thus facilitating ECM modification, ultimately leading to improved efficacy of chemotherapeutics in multi-drug resistant murine colon and breast carcinoma [112]. The gene discussed is CD8A; the disease is neoplasm.